Watts Ryan J. 4
4 · Denali Therapeutics Inc. · Filed Jan 11, 2024
Insider Transaction Report
Form 4
Watts Ryan J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-01-09$19.78/sh−7,818$154,640→ 2,268,363 total(indirect: See footnote)
Holdings
- 221,897
Common Stock
Footnotes (4)
- [F1]Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.
- [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.60 to $20.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
- [F4]Includes 221,897 RSUs.